Literature DB >> 24811391

Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study.

Satoshi Hoshide1, Michiaki Nagai, Yuichiro Yano, Joji Ishikawa, Kazuo Eguchi, Kazuomi Kario.   

Abstract

Although both high-sensitivity cardiac troponin T (Hs-cTnT) and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) levels are higher among patients with cardiac structural abnormalities than among those with apparently normal hearts, there is considerable overlap between the groups. The authors evaluated 1336 patients who had ≥1 cardiovascular risk factors, underwent echocardiography, and had Hs-cTnT and NT-proBNP measured and excluded patients with left ventricular (LV) dysfunction. The patients in the highest Hs-cTnT category in quintiles had an increased likelihood of abnormal relative wall thickness compared with those in the lowest category (odds ratio, 1.66; 95% confidence interval, 1.17-2.36; P<.01). However, no such association was found in the category of NT-proBNP. The patients in the highest NT-proBNP category had an increased likelihood of abnormal LV diastolic dimension/body surface area compared with those in the lowest category (odds ratio, 2.11; 95% confidence interval, 1.17-3.79; P<.05). However, no such association was found in the category of Hs-cTnT. The data suggest that the measurement of Hs-cTnT and NT-proBNP might provide information on cardiac structural abnormalities. ©2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24811391      PMCID: PMC8032029          DOI: 10.1111/jch.12321

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White
Journal:  J Am Coll Cardiol       Date:  2007-11-27       Impact factor: 24.094

2.  Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy.

Authors:  Chiho Kawahara; Takayoshi Tsutamoto; Keizo Nishiyama; Masayuki Yamaji; Hiroshi Sakai; Masanori Fujii; Takashi Yamamoto; Minoru Horie
Journal:  Circ J       Date:  2010-12-17       Impact factor: 2.993

3.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-10-02       Impact factor: 24.094

4.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.

Authors:  James A de Lemos; Mark H Drazner; Torbjorn Omland; Colby R Ayers; Amit Khera; Anand Rohatgi; Ibrahim Hashim; Jarett D Berry; Sandeep R Das; David A Morrow; Darren K McGuire
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

5.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

6.  Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy.

Authors:  Olakunle O Akinboboye; Ru-Ling Chou; Steven R Bergmann
Journal:  Am J Hypertens       Date:  2004-05       Impact factor: 2.689

7.  Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.

Authors:  E M Ohman; P W Armstrong; R H Christenson; C B Granger; H A Katus; C W Hamm; M A O'Hanesian; G S Wagner; N S Kleiman; F E Harrell; R M Califf; E J Topol
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

8.  Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.

Authors:  Ian J Neeland; Mark H Drazner; Jarett D Berry; Colby R Ayers; Christopher deFilippi; Stephen L Seliger; Vijay Nambi; Darren K McGuire; Torbjørn Omland; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

Review 9.  Hypertrophy of the heart: a new therapeutic target?

Authors:  Norbert Frey; Hugo A Katus; Eric N Olson; Joseph A Hill
Journal:  Circulation       Date:  2004-04-06       Impact factor: 29.690

10.  Prognostic significance of left ventricular mass change during treatment of hypertension.

Authors:  Richard B Devereux; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine Harris; Peter Aurup; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  2 in total

1.  Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study.

Authors:  Satoshi Hoshide; Michiaki Nagai; Yuichiro Yano; Joji Ishikawa; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-05-08       Impact factor: 3.738

2.  Growth Differentiation Factor-15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J-HOP Study.

Authors:  Keita Negishi; Satoshi Hoshide; Masahisa Shimpo; Hiroshi Kanegae; Kazuomi Kario
Journal:  J Am Heart Assoc       Date:  2021-12-10       Impact factor: 6.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.